Helicobacter pylori infection and atrophic gastritis

African Health Sciences

Volumn 13, Issue 1, 2013, Pages 112-117

  Ebule, Alonge Ivo ^a   Longdoh, A N ^b   Paloheimo, I L ^c  

^a UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^b UNIVERSITY OF BUEA   (Cameroon)

^c Biohit PLC   (Finland)

Author keywords

Atrophic gastritis; Gastrin; Helicobacter pylori; Pepsinogen

Indexed keywords

BACTERIUM ANTIBODY; GASTRIN 17; HELICOBACTER PYLORI ANTIBODY; PEPSINOGEN I; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; ATROPHIC GASTRITIS; BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DYSPEPSIA; ENZYME IMMUNOASSAY; FEMALE; GASTRIN BLOOD LEVEL; HELICOBACTER INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PEPSINOGEN 1 BLOOD LEVEL; PREVALENCE; PUBLIC HOSPITAL; STOMACH ANTRUM; STOMACH ATROPHY;

ATROPHIC GASTRITIS; GASTRIN; HELICOBACTER PYLORI; PEPSINOGEN;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; ANTIBODIES, BACTERIAL; CAMEROON; CROSS-SECTIONAL STUDIES; DYSPEPSIA; FEMALE; GASTRINS; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; PEPSINOGEN A; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 84876249830     PISSN: 16806905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Di Mario F, Franzè A, Cavallaro L.G. Noninvasive approach to diagnosis of upper gastrointestinal diseases. AREA QUALITÀ s.r.l. 2008;1:5-64.
2. Härkönen M, Laxen F, Nikulin M, Nilson I, Sande N, Sipponen P, Suovaniemi O, and Wadstrom T. Increased risk of developing atrophic gastritis in patients infected with Cag+ Helicobacter pylori. Scand J Gastroenterol. 2001; 36:928-933.
3. WWW.biohit.com/diagnostics-servicelaboratory/www.biohit.com/gastropanel-gastropanel research applications. May 15th 2011
4. Biohit plc (2002-2005), Helsinki, Finland. Diagnostics-Literature.
5. Ivaskin V, Lapina Report the final on the reliability of ELISA test panel of serum level of PGI, G-17 and H. pylori antibodies in patients with peptic ulcer and gastritis. Russian J Gastroenterol 2004;1-4.
6. Bergeret M, Dupont C, Kalach N, Legoede J, Raymond J, and Wanne A. Serum levels of pepsinogen 1, pepsinogenII and gastrin-17 in the course of Helicobacter pylori gastritis in pediatrics. Letters to the editor. J Pediatric Gastroenterol Nutr. 2004; 39:568-570.
7. Väänänen H, Vauhkonne M, Helske T, Kääriänen I, Rasmussen M, Tunturi H, Koskenpato J, Sotkha M, Turunen M, Sandströmme R, Ristikankare M, Jussila A, and Sipponen P. Non endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen 1: A multicenter study. Lippincott &Wilkins 2003;1-4.
8. Correa P. Human gastric carcinogens: A multistep and multifactorial process. First American cancer society award lecture on cancer epidemiology and prevention. Cancer 1992;52:6735-42.
9. Kiyohira K, Yoshihara M, Iio M, Haruma K, Tanaka S, Chayama K. Serum pepsinogen concentrations as a marker of Helicobacter pyloriinfection and histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levels. J Gastroenterol. 2003; 38:332-8.
10. Pasechnikov Victor D, Sergey Chukov Z, Sergey Kotelevets M, Alexander Mostovov N, Varvara Mernova P, and Maria Polyakova. Invasive and Non-invasive diagnosis of Helicobacter pylori associated atrophic gastritis: A comparative study. Scand J Gastroenterol. 2005;40:297-301.
11. Nicolin G, Zagari R, Pozzato P, Lunedei V, Delura L, Antonini F. Diagnosis of atrophic gastritis based upon a combination of three noninvasive tests. Preliminary results of the Loiano-Monghidoro project. J Gastroenterol Hepathol 2002;A264; Dig Liver Dis. 2001;33.
12. Suovaniemi O, Harkonen M, Paloheimo L, Sipponen P. Gastro panel: Diagnosing atrophic gastritis from serum providing a tool for evidenced-based medicine-Business Briefing Global Health Care. www.biohit.com.2003; 1-4.